Brokerages Set FIGS, Inc. (NYSE:FIGS) Price Target at $5.30

Shares of FIGS, Inc. (NYSE:FIGS) have received an average rating of “Reduce” from the seven analysts that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $5.30.

Several analysts recently issued reports on FIGS shares. Roth Mkm lowered their price target on FIGS from $7.50 to $6.75 and set a “buy” rating for the company in a report on Friday, May 10th. Oppenheimer lowered shares of FIGS from an “outperform” rating to a “market perform” rating in a report on Friday, March 8th. Bank of America restated an “underperform” rating and set a $4.50 target price (down from $8.50) on shares of FIGS in a research note on Tuesday, April 2nd. Telsey Advisory Group reissued a “market perform” rating and issued a $6.00 price target on shares of FIGS in a report on Thursday, June 13th. Finally, The Goldman Sachs Group dropped their price target on shares of FIGS from $4.85 to $4.25 and set a “sell” rating for the company in a research note on Tuesday, April 23rd.

Insider Activity at FIGS

In other FIGS news, insider Heather L. Hasson sold 28,614 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $4.89, for a total value of $139,922.46. Following the sale, the insider now directly owns 468,870 shares in the company, valued at $2,292,774.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold 31,644 shares of company stock worth $155,648 in the last 90 days. 22.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On FIGS

Several hedge funds and other institutional investors have recently made changes to their positions in FIGS. Wellington Management Group LLP bought a new stake in FIGS during the 3rd quarter valued at $4,306,000. Barclays PLC increased its stake in FIGS by 62.6% during the 3rd quarter. Barclays PLC now owns 85,715 shares of the company’s stock valued at $507,000 after buying an additional 33,003 shares during the period. Bamco Inc. NY raised its position in shares of FIGS by 6.2% during the 3rd quarter. Bamco Inc. NY now owns 25,032,830 shares of the company’s stock worth $147,694,000 after buying an additional 1,470,706 shares in the last quarter. Eagle Asset Management Inc. bought a new position in shares of FIGS in the fourth quarter valued at approximately $12,152,000. Finally, SG Americas Securities LLC increased its stake in shares of FIGS by 64.3% during the fourth quarter. SG Americas Securities LLC now owns 49,467 shares of the company’s stock valued at $344,000 after acquiring an additional 19,353 shares during the period. 92.21% of the stock is currently owned by institutional investors and hedge funds.

FIGS Trading Up 5.6 %

NYSE FIGS opened at $5.63 on Tuesday. The business’s 50-day moving average price is $5.20 and its 200 day moving average price is $5.60. FIGS has a twelve month low of $4.30 and a twelve month high of $8.37. The company has a market capitalization of $958.39 million, a PE ratio of 51.19, a price-to-earnings-growth ratio of 71.07 and a beta of 1.42.

FIGS (NYSE:FIGS) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. The company had revenue of $119.29 million for the quarter, compared to analyst estimates of $117.38 million. FIGS had a net margin of 4.07% and a return on equity of 6.12%. FIGS’s revenue for the quarter was down .8% on a year-over-year basis. During the same quarter last year, the business earned $0.01 EPS. Equities analysts predict that FIGS will post 0.03 EPS for the current year.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.